Finnish biomaterials company Spinnova has reported revenues of more than €7.6 million for the first half of 2022, which is substantially more than the full-year figure it reported for whole of 2021.

The start-up company is still some way short of being profitable, but it has reduced its net debt and increased the number of its full-time employees by 40% compared to a year ago, reaching 69 at the mid-point of 2022.

Share this story: